Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23855822 | 1.00 | KDM4E (0.42) | KDM4EL3MBTL1ATMGPR3DUSP3 | |
| SCHEMBL12258327 | 0.86 | KDM4E (0.46) | KDM4EL3MBTL1ATMGPR3DUSP3 | |
| SCHEMBL23177382 | 0.78 | KDM4E (0.43) | KDM4EL3MBTL1ATMGPR3DUSP3 | |
| SCHEMBL21562771 | 0.78 | KDM4E (0.44) | KDM4EL3MBTL1ATMGPR3DUSP3 | |
| SCHEMBL29412290 | 0.77 | ALDH1A1 (0.43) | KDM4EL3MBTL1ATMALDH1A1MAPT | |
| SCHEMBL21462450 | 0.77 | ALDH1A1 (0.43) | KDM4EL3MBTL1ATMALDH1A1MAPT | |
| SCHEMBL20252390 | 0.75 | KDM4E (0.48) | KDM4EL3MBTL1ATMGPR3DUSP3 | |
| SCHEMBL21562747 | 0.75 | KDM4E (0.41) | KDM4EL3MBTL1ATMALDH1A1MAPT | |
| SCHEMBL30777263 | 0.75 | ALDH1A1 (0.47) | KDM4EL3MBTL1ATMDUSP3CYP1A2 | |
| SCHEMBL23177403 | 0.74 | ACP1 (0.45) | KDM4EL3MBTL1ATMPOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029116-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2024-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029116-B2 | Composition of matter for use in organic light-emitting diodes | OPRD1, DRD1, DRD3 | KDM4E 3197/4885L3MBTL1 442/4885ATM 3673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.